Suppr超能文献

丙型肝炎病毒与抗病毒固有免疫:拔河比赛谁能获胜?

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

作者信息

Yang Da-Rong, Zhu Hai-Zhen

机构信息

Da-Rong Yang, Hai-Zhen Zhu, Department of Molecular Medicine of College of Biology, State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan University, Changsha 410082, Hunan Province, China.

出版信息

World J Gastroenterol. 2015 Apr 7;21(13):3786-800. doi: 10.3748/wjg.v21.i13.3786.

Abstract

Hepatitis C virus (HCV) is a major human pathogen of chronic hepatitis and related liver diseases. Innate immunity is the first line of defense against invading foreign pathogens, and its activation is dependent on the recognition of these pathogens by several key sensors. The interferon (IFN) system plays an essential role in the restriction of HCV infection via the induction of hundreds of IFN-stimulated genes (ISGs) that inhibit viral replication and spread. However, numerous factors that trigger immune dysregulation, including viral factors and host genetic factors, can help HCV to escape host immune response, facilitating viral persistence. In this review, we aim to summarize recent advances in understanding the innate immune response to HCV infection and the mechanisms of ISGs to suppress viral survival, as well as the immune evasion strategies for chronic HCV infection.

摘要

丙型肝炎病毒(HCV)是导致慢性肝炎及相关肝脏疾病的主要人类病原体。固有免疫是抵御外来病原体入侵的第一道防线,其激活依赖于几种关键感受器对这些病原体的识别。干扰素(IFN)系统通过诱导数百种干扰素刺激基因(ISG)来限制HCV感染,这些基因可抑制病毒复制和传播,发挥着至关重要的作用。然而,包括病毒因素和宿主遗传因素在内的众多引发免疫失调的因素,可帮助HCV逃避免疫反应,促进病毒持续存在。在本综述中,我们旨在总结在理解HCV感染的固有免疫反应、ISG抑制病毒存活的机制以及慢性HCV感染的免疫逃逸策略方面的最新进展。

相似文献

1
Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
World J Gastroenterol. 2015 Apr 7;21(13):3786-800. doi: 10.3748/wjg.v21.i13.3786.
2
Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
Cell Mol Immunol. 2016 Jan;13(1):11-35. doi: 10.1038/cmi.2014.127. Epub 2014 Dec 29.
3
DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.
5
Innate and adaptive immune responses in HCV infections.
J Hepatol. 2014 Nov;61(1 Suppl):S14-25. doi: 10.1016/j.jhep.2014.06.035. Epub 2014 Nov 3.
7
Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):2018-2023. doi: 10.1073/pnas.1614623114. Epub 2017 Feb 3.
9
Subversion of innate host antiviral strategies by the hepatitis C virus.
Arch Biochem Biophys. 2007 Jun 15;462(2):254-65. doi: 10.1016/j.abb.2007.03.033. Epub 2007 Apr 16.
10
Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity.
J Hepatol. 2013 Jul;59(1):52-8. doi: 10.1016/j.jhep.2013.03.019. Epub 2013 Mar 28.

引用本文的文献

1
Association between heavy metals exposure and persistent infections: the mediating role of immune function.
Front Public Health. 2024 Jul 22;12:1367644. doi: 10.3389/fpubh.2024.1367644. eCollection 2024.
2
Toll-like Receptor Response to Hepatitis C Virus Infection: A Recent Overview.
Int J Mol Sci. 2022 May 13;23(10):5475. doi: 10.3390/ijms23105475.
3
Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections.
J Immunol Res. 2020 May 8;2020:1372494. doi: 10.1155/2020/1372494. eCollection 2020.
5
Long Non-coding RNAs in Hepatitis C Virus-Infected Cells.
Front Microbiol. 2017 Sep 28;8:1833. doi: 10.3389/fmicb.2017.01833. eCollection 2017.
7
Oxidative Stress and Immune Responses During Hepatitis C Virus Infection in Tupaia belangeri.
Sci Rep. 2017 Aug 29;7(1):9848. doi: 10.1038/s41598-017-10329-7.
9
Adaptive immunity in the liver.
Cell Mol Immunol. 2016 May;13(3):354-68. doi: 10.1038/cmi.2016.4. Epub 2016 Mar 21.

本文引用的文献

1
Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90.
PLoS Pathog. 2014 Oct 2;10(10):e1004424. doi: 10.1371/journal.ppat.1004424. eCollection 2014 Oct.
2
Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes.
J Virol. 2014 Aug;88(15):8433-44. doi: 10.1128/JVI.00081-14. Epub 2014 May 14.
3
MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a.
PLoS One. 2014 Apr 11;9(4):e94501. doi: 10.1371/journal.pone.0094501. eCollection 2014.
4
Inhibition of hepatitis C virus infection by NS5A-specific aptamer.
Antiviral Res. 2014 Jun;106:116-24. doi: 10.1016/j.antiviral.2014.03.020. Epub 2014 Apr 5.
5
Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity.
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5646-51. doi: 10.1073/pnas.1401674111. Epub 2014 Mar 27.
6
Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line.
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):E1264-73. doi: 10.1073/pnas.1320071111. Epub 2014 Mar 10.
7
Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein.
PLoS One. 2014 Feb 28;9(2):e90333. doi: 10.1371/journal.pone.0090333. eCollection 2014.
8
Inhibition of hepatitis C virus production by aptamers against the core protein.
J Virol. 2014 Feb;88(4):1990-9. doi: 10.1128/JVI.03312-13. Epub 2013 Dec 4.
9
On the history of hepatitis C virus cell culture systems.
J Med Chem. 2014 Mar 13;57(5):1627-42. doi: 10.1021/jm401401n. Epub 2013 Nov 21.
10
Chimeric mouse model for the infection of hepatitis B and C viruses.
PLoS One. 2013 Oct 14;8(10):e77298. doi: 10.1371/journal.pone.0077298. eCollection 2013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验